181 related articles for article (PubMed ID: 31215145)
21. SALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial Cancer.
Liu L; Zhang J; Yang X; Fang C; Xu H; Xi X
PLoS One; 2015; 10(9):e0138515. PubMed ID: 26407074
[TBL] [Abstract][Full Text] [Related]
22. IL-37bΔ1-45 suppresses the migration and invasion of endometrial cancer cells by targeting the Rac1/NF-κB/MMP2 signal pathway.
Wang X; Wei Z; Tang Z; Xue C; Yu H; Zhang D; Li Y; Liu X; Shi Y; Zhang L; Chen G; Zhou H; Wang J; Wang X
Lab Invest; 2021 Jun; 101(6):760-774. PubMed ID: 33753880
[TBL] [Abstract][Full Text] [Related]
23. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
[TBL] [Abstract][Full Text] [Related]
24. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
Dai D; Kumar NS; Wolf DM; Leslie KK
Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185
[TBL] [Abstract][Full Text] [Related]
25. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition.
Wen Y; Tan X; Wu X; Wu Q; Qin Y; Liang M; Ran G; Gu H; Xie R
Cancer Biomark; 2019; 26(1):21-30. PubMed ID: 31322544
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of TIF1γ by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-β/Smad signaling pathway.
Qi G; Lu G; Yu J; Zhao Y; Wang C; Zhang H; Xia Q
Eur J Pharmacol; 2019 Oct; 860():172551. PubMed ID: 31323225
[TBL] [Abstract][Full Text] [Related]
27. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
[TBL] [Abstract][Full Text] [Related]
28. High Glucose Promotes Epithelial-Mesenchymal Transition of Uterus Endometrial Cancer Cells by Increasing ER/GLUT4-Mediated VEGF Secretion.
Gu CJ; Xie F; Zhang B; Yang HL; Cheng J; He YY; Zhu XY; Li DJ; Li MQ
Cell Physiol Biochem; 2018; 50(2):706-720. PubMed ID: 30308493
[TBL] [Abstract][Full Text] [Related]
29. Brusatol sensitizes endometrial hyperplasia and cancer to progestin by suppressing NRF2-TET1-AKR1C1-mediated progestin metabolism.
Hu M; Sun D; Yu J; Fu Y; Qin Z; Huang B; Zhang Q; Chen X; Wei Y; Zhu H; Wang Y; Feng Y; Zheng W; Liao H; Li J; Wu S; Zhang Z
Lab Invest; 2022 Dec; 102(12):1335-1345. PubMed ID: 36038734
[TBL] [Abstract][Full Text] [Related]
30. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma.
Liu C; Peng X; Li Y; Liu S; Hou R; Zhang Y; Zuo S; Liu Z; Luo R; Li L; Fang W
Biomed Pharmacother; 2020 Mar; 123():109780. PubMed ID: 31901550
[TBL] [Abstract][Full Text] [Related]
31. Ginsenoside Rh2 induces apoptosis and inhibits epithelial-mesenchymal transition in HEC1A and Ishikawa endometrial cancer cells.
Kim JH; Kim M; Yun SM; Lee S; No JH; Suh DH; Kim K; Kim YB
Biomed Pharmacother; 2017 Dec; 96():871-876. PubMed ID: 29078265
[TBL] [Abstract][Full Text] [Related]
32. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation.
Wu K; Chen K; Wang C; Jiao X; Wang L; Zhou J; Wang J; Li Z; Addya S; Sorensen PH; Lisanti MP; Quong A; Ertel A; Pestell RG
Cancer Res; 2014 Feb; 74(3):829-39. PubMed ID: 24335958
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of long non-coding HOTAIR enhances the sensitivity to progesterone in endometrial cancer by epigenetic regulation of progesterone receptor isoform B.
Chi S; Liu Y; Zhou X; Feng D; Xiao X; Li W; Zhao Y; Wang H
Cancer Chemother Pharmacol; 2019 Feb; 83(2):277-287. PubMed ID: 30443761
[TBL] [Abstract][Full Text] [Related]
34. NrCAM secreted by endometrial stromal cells enhances the progestin sensitivity of endometrial cancer cells through epigenetic modulation of PRB.
Cheng Y; Xie L; Xu Z; Hao M; Yang B; Shan W; Wang Y; Lv Q; Chen X
Cancer Gene Ther; 2022 Oct; 29(10):1452-1462. PubMed ID: 35388173
[TBL] [Abstract][Full Text] [Related]
35. Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma.
Wei L; Ma X; Hou Y; Zhao T; Sun R; Qiu C; Liu Y; Qiu Z; Liu Z; Jiang J
Cell Death Discov; 2023 Jan; 9(1):30. PubMed ID: 36693834
[TBL] [Abstract][Full Text] [Related]
36. Thyroid Hormone Receptor β Knockdown Reduces Suppression of Progestins by Activating the mTOR Pathway in Endometrial Cancer Cells.
Ren B; Zhou J; Hu Y; Zhong R; Lv Q; Xie S; Li G; Yang B; Chen X; Zhu Y
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293372
[TBL] [Abstract][Full Text] [Related]
37. Polyphyllin I Overcomes EMT-Associated Resistance to Erlotinib in Lung Cancer Cells via IL-6/STAT3 Pathway Inhibition.
Lou W; Chen Y; Zhu KY; Deng H; Wu T; Wang J
Biol Pharm Bull; 2017 Aug; 40(8):1306-1313. PubMed ID: 28515374
[TBL] [Abstract][Full Text] [Related]
38. Suppression of DACH1 promotes migration and invasion of colorectal cancer via activating TGF-β-mediated epithelial-mesenchymal transition.
Wang P
Biochem Biophys Res Commun; 2015 May; 460(2):314-9. PubMed ID: 25778865
[TBL] [Abstract][Full Text] [Related]
39. Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
van der Horst PH; Wang Y; Vandenput I; Kühne LC; Ewing PC; van Ijcken WF; van der Zee M; Amant F; Burger CW; Blok LJ
PLoS One; 2012; 7(1):e30840. PubMed ID: 22295114
[TBL] [Abstract][Full Text] [Related]
40. Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo.
Xie M; He CS; Wei SH; Zhang L
Eur J Cancer; 2013 Nov; 49(16):3559-72. PubMed ID: 23916913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]